Drug Approval | August 16, 2025
Zydus’ SEZ II, Ahmedabad plant clears USFDA inspection with nil observations
The inspection concluded with NIL observations
The inspection concluded with NIL observations
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Eugia Pharma Specialities restarts production at terminally sterilized product lines
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
The company will address the observations within a stipulated timeline working with the regulators
_256_384.jpg)
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
Prucalopride is prescribed for chronic idiopathic constipation
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
This is the group’s first NoC approval in Canada
Subscribe To Our Newsletter & Stay Updated
